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CASE REPORTPleomorphic soft tissue sarcoma metastatic to the
skin of the scalp and groin
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Rarely, the dermatologistmay encounter a primary
cutaneous pleomorphic sarcoma (also known as a
malignant fibrous histiocytoma), an undifferentiated
neoplasm thought to be of mesenchymal origin.1
These uncommon skin tumors typically manifest as
tender subcutaneous nodules. In contrast to primary
cutaneous sarcomas, we present a case of a soft tissue
pleomorphic sarcomawithmultiple metastases to the
cutaneous scalp and the groin. Although previous
reports have described leiomyosarcoma metastatic to
the skin, no report to our knowledge has detailed a
widely metastatic undifferentiated sarcoma with le-
sions in multiple skin sites.
CASE REPORT
A 75-year-old white man with a history of prostate
cancer treated with radiotherapy presented to his
primary care physician with reproducible chest,
back, and shoulder pain; painless swelling in his
left leg; and nodules on the skin of his scalp and
groin. The patient returned home with a trial of
cyclobenzaprine for presumed musculoskeletal
strain and a planned outpatient dermatology ap-
pointment. Within a month, the patient returned to
the emergency department with severe weakness,
confusion, anorexia, and purulent, bloody drainage
from several scalp nodules. Skin examination found
multiple flesh-colored to violaceous nodules, the
most prominent located on the patient’s inguinal
groin and vertex scalp (Fig 1). The largest scalp
lesion measured approximately 2 cm3 and had cen-
tral crusting and ulceration (Fig 1, right panel).the Division of Dermatologya and the Department of
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u.Musculoskeletal examination found a left thigh
larger than the right, but strength, range of motion,
and gait were normal. Initial laboratory results were
remarkable for a white blood cell count of 20,000/L,
Hgb of 10 g/dL, Ca21 of 10.5 mg/dL, and an alkaline
phosphatase level of 326 IU/L. Chest, abdomen, and
pelvis computed tomography scan showed destruc-
tion of the rib architecture and multiple small pul-
monary masses. Brain magnetic resonance images
showed enhancing lesions in the temporal lobe,
frontal lobe, and the scalp. None of these scalp
lesions arose in or invaded the calvaria. A left femoral
radiograph showed a large ([10 cm) soft tissue
mass. Before transfer to our facility, the patient
underwent biopsies of the thigh mass and left femur.
Both biopsies showed indeterminate findings.
After transfer to our facility, the dermatology
service obtained a punch biopsy section of a cu-
taneous lesion from the right inguinal area. Routine
histology found a dense proliferation of atypical
dermal spindle cells with approximately 25 mitotic
figures per square millimeter (Fig 2). Lesional
cells completely effaced the normal cutaneous archi-
tecture, and the biopsy section transected the base
of the lesion. Lesional cells were positive for
vimentin, negative for pancytokeratin, S-100, SMA,
desmin, CD34, CD31, c-Kit, HMB45, and Melan-A.
Esophagogastroduodenoscopy-guided biopsy of
gastric and duodenal ulcers showed similar
vimentin-positive atypical spindle cells. Given this
immunohistochemical profile—and the lack of any
evidence of spindle cell maturation from either
biopsy—no additional immunohistochemistry (eg,JAAD Case Reports 2015;1:96-8.
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Fig 1. Examination found multiple flesh-colored to violaceous nodules, the most prominent
located on the inguinal groin and vertex scalp (left and right panel, respectively).
Fig 2. Histology of a cutaneous lesion from the right inguinal area shows a dense proliferation
of atypical spindle cells within the dermis with approximately 25 atypical mitotic figures per
square millimeter, findings consistent with a high-grade pleomorphic sarcoma. (Hematoxylin-
eosin stain.)
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formed. In all, the findings led to a diagnosis of
widely metastatic high-grade pleomorphic spindle
cell sarcoma arising from a largemass in the left thigh.The patient received treatment for hypercalcemia,
hemorrhagic shock caused by bleeding malignant
ulcers, and hypoxemic respiratory failure caused by
metastatic burden in his lungs. Despite aggressive
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continued to deteriorate, and the family decided to
transition the patient to comfort care only. The
patient died from respiratory complications 7 days
after initial hospitalization.
DISCUSSION
Sarcoma arising in any location has a worldwide
incidence estimated at 1.8 to 5 cases per 100,000
persons per year, with most arising in individuals
over the age of 55.2 The most common subtypes
include gastrointestinal stromal tumors (about 1 in
5), unclassified (about 1 in 6), liposarcoma (about 1
in 6), and leiomyosarcoma (about 1 in 10).3 Based
on histologic features, including morphology and
frequency of mitotic cells, the National Cancer
Institute guidelines classify sarcomas as low, me-
dium, or high grade, a designation carrying prog-
nostic and therapeutic significance.4 For solitary
lesions—including those arising in the skin—treat-
ment consists of local resection and, depending on
histology and staging, either preoperative or post-
operative chemoradiotherapy. Sarcoma preferen-
tially metastasizes to the lung and bones (as in this
case), and metastatic sarcoma poses a great thera-
peutic challenge. Response to chemoradiotherapy
hinges on tumor behavior, histologic subtype, and
patient characteristics. A recent study showed the
most favorable chemotherapeutic outcomes in pa-
tients with liposarcoma or synovial histology, with
no bone metastases, and who were less than 40
years old.5 Regardless, prognosis remains guarded,
and median survival in metastatic disease is approx-
imately 1 year.
Of note, soft tissue sarcomas of all histologic
subtypes rarely metastasize to the skin. A retrospec-
tive study from MD Anderson Cancer Center
encompassing 20 years of data and 25,000 histolog-
ically confirmed sarcoma cases found skin metasta-
ses in only 65 cases (0.26% of all sarcoma cases). Ofthose 65 cases, leiomyosarcoma was the most
frequent subtype (28 of 65; 43%), with only 4 cases
(6%) of pleomorphic sarcoma/malignant fibrous
histiocytoma metastatic to the skin.6 Concordant
with this study, several reports have detailed cuta-
neous nodules as the presenting sign of metastatic
leiomyosarcoma, but very few publications have
noted pleomorphic sarcoma metastatic to the
skin.7,8 Moreover, this is the first such case of which
we are aware of a high-grade pleomorphic sarcoma
arising in the soft tissue and metastasizing to multi-
ple distinct anatomic skin sites. Despite this unusual
diagnosis carrying a poor prognosis, the derma-
tology service was able to facilitate care by quickly
refining a definitive diagnosis using a minimally
invasive technique.
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